The peroxisome proliferator-activated receptor agonist rosiglitazone specifically represses tumour metastatic potential in chromatin inaccessibility-mediated FABP4-deficient gastric cancer

Background: Efforts to prevent recurrence in gastric cancer (GC) patients are limited by current incomplete understanding of the pathological mechanisms. The present study aimed to identify novel tumour metastasis-associated genes and investigate potential value of these genes in clinical diagnosis...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Qi-Yue, Huang, Xiao-Bo, Zhao, Ya-Jun, Wang, Hua-Gen, Wang, Jia-Bin, Liu, Li-Chao, Wang, Ling-Qian, Zhong, Qing, Xie, Jian-Wei, Lin, Jian-Xian, Lu, Jun, Cao, Long-Long, Lin, Mi, Tu, Ru-Hong, Zheng, Chao-Hui, Li, Ping, Huang, Chang-Ming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825587/
https://www.ncbi.nlm.nih.gov/pubmed/35198079
http://dx.doi.org/10.7150/thno.66814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8825587/
https://www.ncbi.nlm.nih.gov/pubmed/35198079
http://dx.doi.org/10.7150/thno.66814

Ejemplares similares